NEOadjuvant Abemaciclib and GIredestrant TriaL in Patients with ER-positive, HER2-negative Early Breast Cancer
Clinical trial NCT06259929 · RECRUITING
Trial details
- NCT number
- NCT06259929
- Sponsor
- Fondazione Oncotech
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-27
- Primary completion
- 2026-04-01
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.